Literature DB >> 20190474

Acute kidney injury caused by zonisamide-induced hypersensitivity syndrome.

Yoshiro Fujita1, Midori Hasegawa, Kuihiro Nabeshima, Makoto Tomita, Kazutaka Murakami, Shigeru Nakai, Takashi Yamakita, Kayoko Matsunaga.   

Abstract

Drug rash with eosinophilia and systemic symptoms (DRESS), also known as drug-induced hypersensitivity syndrome (DIHS), is a severe adverse drug reaction affecting multiple organs caused by drug treatment. The current report describes a man who was prescribed zonisamide for epilepsy and subsequently developed widespread skin rash, acute kidney injury, high-grade fever, eosinophilia, liver dysfunction, lymphadenopathy and an increase in antihuman herpesvirus-6 immunoglobulin G titer. Hypersensitivity to zonisamide was confirmed by the skin patch test. Based on these findings, the patient was diagnosed with DRESS/DIHS caused by zonisamide. This is the first report of acute kidney injury due to zonisamide-induced DRESS/DIHS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20190474     DOI: 10.2169/internalmedicine.49.2451

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  9 in total

1.  Garcinia Cambogia-Induced Acute Hepatitis; Varenicline-Induced Parkinsonism; Resistant Hypocalcemia After Zoledronic Acid Administration; Zonisamide-Induced Acute Kidney Injury; Psychosis Associated with Guanfacine.

Authors:  Michael A Mancano
Journal:  Hosp Pharm       Date:  2015-07-31

2.  Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome in a paediatric patient taking zonisamide.

Authors:  Ashifa Trivedi; Sadhna Sharma; Ranjith Govindan
Journal:  Eur J Hosp Pharm       Date:  2020-10-26

3.  Development of a knowledge mining approach to uncover heterogeneous risk predictors of acute kidney injury across age groups.

Authors:  Lijuan Wu; Yong Hu; Xiangzhou Zhang; Jia Zhang; Mei Liu
Journal:  Int J Med Inform       Date:  2021-12-09       Impact factor: 4.730

Review 4.  Cutaneous Adverse Effects of Neurologic Medications.

Authors:  Eman Bahrani; Chloe E Nunneley; Sylvia Hsu; Joseph S Kass
Journal:  CNS Drugs       Date:  2016-03       Impact factor: 6.497

5.  The Link between Hypersensitivity Syndrome Reaction Development and Human Herpes Virus-6 Reactivation.

Authors:  Joshua C Pritchett; Radu M Nanau; Manuela G Neuman
Journal:  Int J Hepatol       Date:  2012-05-16

6.  Zonisamide-induced acute kidney injury.

Authors:  Deepali Dixit; Diana Stewart; Mary M Bridgeman; Amay Parikh
Journal:  Epilepsy Behav Case Rep       Date:  2015-03-21

7.  Comparing Zonisamide With Sodium Valproate in the Management of Migraine Headaches: Double-Blind Randomized Clinical Trial of Efficacy and Safety.

Authors:  Farhad Assarzadegan; Hanif Tabesh; Seyed-Mostafa Hosseini-Zijoud; Andrew David Beale; Arya Shoghli; Mahmood Ghafoori Yazdi; Behnam Mansouri; Omid Hesami; Nahid Beladi Moghadam; Hosein Delavar Kasmaei
Journal:  Iran Red Crescent Med J       Date:  2016-04-30       Impact factor: 0.611

8.  Acute tubular necrosis as a part of vancomycin induced drug rash with eosinophilia and systemic symptoms syndrome with coincident postinfectious glomerulonephritis.

Authors:  Kyung Min Kim; Kyoung Sung; Hea Koung Yang; Seong Heon Kim; Hye Young Kim; Gil Ho Ban; Su Eun Park; Hyoung Doo Lee; Su Young Kim
Journal:  Korean J Pediatr       Date:  2016-03-31

9.  Pharmacokinetics of zonisamide after oral single dosing and multiple-dose escalation administration in domestic chickens (Gallus gallus).

Authors:  Ricardo de Matos; Brendan P Noonan; Deanna M W Schaefer; James Morrisey; Curtis Dewey; Elizabeth L Buckles; Dawn Boothe
Journal:  Vet Med Sci       Date:  2021-05-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.